As a result of the newly developed guidelines, laboratories were obligated to develop both diagnostic and carrier screening mutation panels that either were identical to or overlapped with respect to ...

The diagnostics advisory committee reviewed the evidence available on the clinical and cost effectiveness of epidermal growth factor receptor tyrosine kinase (EGFR‑TK) mutation testing to inform first ...